These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 36180657)
21. Talaromyces marneffei and nontuberculous mycobacteria co-infection in HIV-negative patients. Qiu Y; Huang J; Li Y; Zeng W; Pan M; Cen J; Zhang H; Sun X; Qu D; Zhang J Sci Rep; 2021 Aug; 11(1):16177. PubMed ID: 34376749 [TBL] [Abstract][Full Text] [Related]
22. HIV-child with disseminated Talaromyces Marneffei (Penicillium marneffei) infection: a rare severe case report. Hu W; Yu XH; Wei WQ; Xiang X BMC Pediatr; 2022 Jan; 22(1):28. PubMed ID: 34996393 [TBL] [Abstract][Full Text] [Related]
23. Successful voriconazole treatment of Talaromyces marneffei infection in an HIV-negative patient with osteolytic lesions. Ge Y; Xu Z; Hu Y; Huang M J Infect Chemother; 2019 Mar; 25(3):204-207. PubMed ID: 30195473 [TBL] [Abstract][Full Text] [Related]
24. Burden of Talaromyces marneffei infection in people living with HIV/AIDS in Asia during ART era: a systematic review and meta-analysis. Qin Y; Huang X; Chen H; Liu X; Li Y; Hou J; Li A; Yan X; Chen Y BMC Infect Dis; 2020 Jul; 20(1):551. PubMed ID: 32727383 [TBL] [Abstract][Full Text] [Related]
25. Talaromyces marneffei infection with IFNGR1 gene mutation in a patient with negative Anti-Interferon-γ autoantibodies. Li S; Cao X; Guo Z; Wang J; Tong J; Zhang Z An Bras Dermatol; 2024; 99(2):233-237. PubMed ID: 37926601 [TBL] [Abstract][Full Text] [Related]
26. Disseminated Ding X; Huang H; Zhong L; Chen M; Peng F; Zhang B; Cui X; Yang XA Front Cell Infect Microbiol; 2021; 11():605589. PubMed ID: 33791233 [TBL] [Abstract][Full Text] [Related]
27. Rapid and precise diagnosis of Zhang W; Ye J; Qiu C; Wang L; Jin W; Jiang C; Xu L; Xu J; Li Y; Wang L; Jin H Ther Adv Respir Dis; 2020; 14():1753466620929225. PubMed ID: 32482141 [TBL] [Abstract][Full Text] [Related]
28. Clinical features of Talaromyces marneffei infection in HIV-positive and HIV-negative individuals: A retrospective study in southern China. Wang Y; Mo X; Zhang J; Yan Z; Fang Y; Deng W; Xu J; Peng J; Miao Y Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37553136 [TBL] [Abstract][Full Text] [Related]
29. Characteristics and Prognosis of Talaromyces marneffei Infection in Non-HIV-Infected Children in Southern China. Guo J; Li BK; Li TM; Wei FL; Fu YJ; Zheng YQ; Pan KS; Huang CY; Cao CW Mycopathologia; 2019 Dec; 184(6):735-745. PubMed ID: 31473910 [TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics and risk factors for poor prognosis among HIV patients with Talaromyces marneffei bloodstream infection. Sun J; Sun W; Tang Y; Zhang R; Liu L; Shen Y; Wang J; Chen J; Qi T; Wang Z; Song W; Lin Y; Xu S; Lu H BMC Infect Dis; 2021 Jun; 21(1):514. PubMed ID: 34074256 [TBL] [Abstract][Full Text] [Related]
31. Clinical Characteristics of HIV-Associated Talaromyces marneffei Infection of Intestine in Southern China. Xie Z; Lai J; Peng R; Mou M; Liang H; Ning C Int J Infect Dis; 2022 Jul; 120():48-50. PubMed ID: 35398298 [TBL] [Abstract][Full Text] [Related]
32. Innate Immunity Acts as the Major Regulator in Dong RJ; Zhang YG; Zhu L; Liu HL; Liu J; Kuang YQ; Wang RR; Li YY Open Forum Infect Dis; 2019 Jun; 6(6):ofz205. PubMed ID: 31211154 [TBL] [Abstract][Full Text] [Related]
33. Disseminated Talaromyces marneffei infection presenting as multiple intestinal perforations and diffuse hepatic granulomatous inflammation in an infant with STAT3 mutation: a case report. Pan M; Qiu Y; Zeng W; Tang S; Wei X; Zhang J BMC Infect Dis; 2020 Jun; 20(1):394. PubMed ID: 32493232 [TBL] [Abstract][Full Text] [Related]
34. Characteristics and Prognosis of Talaromyces marneffei Infection in HIV-positive Children in Southern China. Xue X; Zou J; Fang W; Liu X; Chen M; Arastehfar A; Ilkit M; Zheng Y; Qin J; Peng Z; Hu D; Liao W; Pan W Mycopathologia; 2022 Jun; 187(2-3):169-180. PubMed ID: 35157189 [TBL] [Abstract][Full Text] [Related]
35. Unusual disseminated Talaromyces marneffei infection mimicking lymphoma in a non-immunosuppressed patient in East China: a case report and review of the literature. Chen D; Chang C; Chen M; Zhang Y; Zhao X; Zhang T; Wang Z; Yan J; Zhu H; Zheng L; Zhao K BMC Infect Dis; 2020 Oct; 20(1):800. PubMed ID: 33115429 [TBL] [Abstract][Full Text] [Related]
36. T. marneffei infection complications in an HIV-negative patient with pre-existing pulmonary sarcoidosis: a rare case report. Yu X; Miao K; Zhou C; Cai Y; Huang X; Chen Y; Chen M; Cai H; Zhang L BMC Infect Dis; 2018 Aug; 18(1):390. PubMed ID: 30097066 [TBL] [Abstract][Full Text] [Related]
37. Clinical, genetic and immunological characteristics of 40 Chinese patients with CD40 ligand deficiency. Du X; Tang W; Chen X; Zeng T; Wang Y; Chen Z; Xu T; Zhou L; Tang X; An Y; Zhao X Scand J Immunol; 2019 Oct; 90(4):e12798. PubMed ID: 31179555 [TBL] [Abstract][Full Text] [Related]
38. Effect and Mechanism of Cotrimoxazole Against Talaromyces marneffei in vitro. Chen J; Chen R; Wei W; Qin F; Chen X; He J; Zhang H; Wang G; Shi M; Qin T; Liao Y; Wu Y; Lu B; Tao X; Ye L; Liang H; Jiang J Mycopathologia; 2022 Dec; 187(5-6):579-593. PubMed ID: 36318375 [TBL] [Abstract][Full Text] [Related]
39. Clinical Characteristics, Laboratory Findings, and Prognosis in Patients With Li D; Liang H; Zhu Y; Chang Q; Pan P; Zhang Y Front Med (Lausanne); 2022; 9():841674. PubMed ID: 35492344 [TBL] [Abstract][Full Text] [Related]
40. Talaromyces marneffei infection and complicate manifestation of respiratory system in HIV-negative children. Yang Q; Wu Y; Li X; Bao Y; Wang W; Zheng Y BMC Pulm Med; 2023 Mar; 23(1):100. PubMed ID: 36978020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]